These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Nirmala PB, Thampan RV. Biochem Biophys Res Commun; 1995 Aug 04; 213(1):24-31. PubMed ID: 7639742 [Abstract] [Full Text] [Related]
7. [Properties of alkylating derivatives of estrogens]. Morozova TM, Merkulova TI, Martynov V, Iaguzhinskaia VP, Shkodinskaia EN. Eksp Onkol; 1984 Aug 04; 6(2):50-4. PubMed ID: 6510335 [Abstract] [Full Text] [Related]
8. Conformational analysis of nonsteroidal estrogens: The effect of conformer populations on the binding affinity of meso- and dl-hexestrol to the estrogen receptor. Kilbourn MR, Arduengo AJ, Park JT, Katzenellenbogen JA. Mol Pharmacol; 1981 May 04; 19(3):388-98. PubMed ID: 6267445 [No Abstract] [Full Text] [Related]
9. Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol. Ouellet R, Rousseau J, Brasseur N, van Lier JE, Diksic M, Westera G. J Med Chem; 1984 Apr 04; 27(4):509-13. PubMed ID: 6323712 [Abstract] [Full Text] [Related]
10. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus]. Fanchenko ND, Alekseeva ML, Minina LS, Novikov EA, Khel'mun DK. Biokhimiia; 1985 Nov 04; 50(11):1853-8. PubMed ID: 4063405 [Abstract] [Full Text] [Related]
11. Binding characteristics of zearalenone analogs to estrogen receptors. Kiang DT, Kennedy BJ, Pathre SV, Mirocha CJ. Cancer Res; 1978 Nov 04; 38(11 Pt 1):3611-5. PubMed ID: 698923 [Abstract] [Full Text] [Related]
12. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Markaverich BM, Roberts RR, Alejandro MA, Clark JH. Cancer Res; 1984 Apr 04; 44(4):1515-9. PubMed ID: 6704964 [Abstract] [Full Text] [Related]
13. The nuclear estrogen receptor R-II of the goat uterus: distinct possibility that the R-II is the deglycosylated form of the nonactivated estrogen receptor (naER). Karthikeyan N, Thampan RV. Arch Biochem Biophys; 1995 Aug 20; 321(2):442-52. PubMed ID: 7544097 [Abstract] [Full Text] [Related]
15. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives. Zablocki JA, Katzenellenbogen JA, Carlson KE, Norman MJ, Katzenellenbogen BS. J Med Chem; 1987 May 20; 30(5):829-38. PubMed ID: 3033242 [Abstract] [Full Text] [Related]
16. Comparison between different forms of estrogen cytosol receptor and the nuclear receptor extracted by micrococcal nuclease. Rochefort H, André J. Cancer Res; 1978 Nov 20; 38(11 Pt 2):4229-32. PubMed ID: 698961 [Abstract] [Full Text] [Related]
18. Biotinylestradiol for purification of estrogen receptor. Redeuilh G, Secco C, Baulieu EE. Methods Enzymol; 1990 Nov 20; 184():292-300. PubMed ID: 2388574 [No Abstract] [Full Text] [Related]
19. A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors. Ratajczak T, Atrache V, Antes P, Comber M, Hähnel R. Steroids; 1988 Nov 20; 51(5-6):499-518. PubMed ID: 3242173 [Abstract] [Full Text] [Related]